In and Out
Could combining inflow and outflow procedures be a new strategy for combating glaucoma?
Philip Bloom | | Longer Read
At a Glance
- Although pharmacologic treatment remains the backbone of glaucoma therapy, there has also been incredible innovation and growth in the surgical device arena, not least MIGS
- Though it is common for a patient to be on a number of topical medications, it is not common practice to combine more than one MIGS procedure to achieve the same end – though perhaps it should be
- Combining procedures – such as ECP with the iStent (3) – makes sense; there is a growing body of real-world experience, both in terms of efficacy and safety
- Though a practice still very much in its infancy, combining procedures should be given the same consideration afforded to the combination of pharmaceutical agents with different mechanisms of action.
Read the full article now
Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE!
Or register now - it’s free!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Ophthalmologist magazine